Upgrade to SI Premium - Free Trial

Cingulate Inc (CING)

5.40 -0.47 (8.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/19/26 *Est.)

Latest Headlines

Form 10-Q Cingulate Inc. For: Jun 30 August 13, 2026 8:46 AM - SEC Filing Form 8-K Cingulate Inc. For: Aug 13 August 13, 2026 8:40 AM - SEC Filing Cingulate posts wider Q2 loss as SG&A spending more than doubles August 13, 2026 8:31 AM - StreetInsider Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness August 13, 2026 8:30 AM - Globe NewsWire Cingulate publishes PK data for ADHD drug CTx-1301 in CNS Drugs August 11, 2026 8:31 AM - StreetInsider Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile August 11, 2026 8:30 AM - Globe NewsWire Cingulate publishes phase 3 ADHD drug trial results in peer-reviewed journal July 30, 2026 8:30 AM - StreetInsider Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology July 30, 2026 8:30 AM - Globe NewsWire Form 8-K Cingulate Inc. For: Jul 17 July 23, 2026 4:06 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Schaffer Shane J. July 20, 2026 7:38 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Downey Bryan Wade July 20, 2026 7:36 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Lawrence Bryan Jay July 20, 2026 7:32 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Brams Matthew July 20, 2026 7:32 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Hargroves Thomas Jeffrey July 20, 2026 7:31 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Callahan Jennifer L. July 20, 2026 7:31 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Werth Peter J. July 20, 2026 7:28 PM - SEC Filing Form 4 Cingulate Inc. For: Jul 16 Filed by: Silva Raul R. July 20, 2026 7:27 PM - SEC Filing Form S-8 Cingulate Inc. July 15, 2026 5:20 PM - SEC Filing Form 8-K Cingulate Inc. For: Jul 09 July 14, 2026 8:00 AM - SEC Filing Form 4 Cingulate Inc. For: Jun 30 Filed by: Silva Raul R. July 2, 2026 6:00 PM - SEC Filing Form 8-K Cingulate Inc. For: Jun 30 July 2, 2026 8:40 AM - SEC Filing Cingulate added to Russell 3000E index July 2, 2026 8:30 AM - StreetInsider Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E® July 2, 2026 8:30 AM - Globe NewsWire Form 8-K Cingulate Inc. For: Jun 16 June 16, 2026 8:10 AM - SEC Filing Cingulate receives first U.S. patent for ADHD drug candidate CTx-1301 June 16, 2026 8:02 AM - StreetInsider Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301 June 16, 2026 8:01 AM - Globe NewsWire Form 4 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey June 8, 2026 7:02 PM - SEC Filing Form 3 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey June 8, 2026 7:00 PM - SEC Filing Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26 June 4, 2026 4:50 PM - StreetInsider Form 8-K Cingulate Inc. For: Jun 02 June 2, 2026 8:10 AM - SEC Filing FDA issues complete response letter for Cingulate's ADHD drug CTx-1301 June 2, 2026 8:01 AM - StreetInsider Cingulate Receives Complete Response Letter from FDA for CTx-1301 June 2, 2026 8:00 AM - Globe NewsWire Cingulate Inc (CING) Halted News Pending June 2, 2026 7:59 AM - StreetInsider Form DEF 14A Cingulate Inc. For: May 29 May 29, 2026 9:17 AM - SEC Filing Form ARS Cingulate Inc. For: Dec 31 May 29, 2026 8:11 AM - SEC Filing Form DEFA14A Cingulate Inc. May 29, 2026 8:05 AM - SEC Filing Full Article List